comprehensive -WSS

comprehensive

author：fashion 2025-10-02 19:39:05 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question: Does early success of the drug, called Relyvrio, make it more complicated, perhaps impossible, to pull it from the market if we find out next year that it doesn’t work?

On Monday night, Amylyx said Relyvrio sales totaled $22 million in 2022 — a period that covers slightly more than one calendar quarter given the drug’s U.S. approval last September. The company said approximately 1,300 ALS patients were on Relyvrio at the end of December, and it expects that number to at least double by the end of the first quarter.

“We’re probably going to double, closer to triple, our revenue in Q1,” said James Frates, Amylyx’s chief financial officer, speaking on Monday night’s conference call.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： It costs an awful lot of money to give away a kidney

explore

WSS

Stigma and the return of syphilis

How to ethically and practically extend health care to all

Focused ultrasound for uterine fibroids: an uphill battle

Lab trade group sues FDA to halt regulation of lab

Health insurers say they are turning to AI to cut costs, improve care

First Opinion Podcast: What happens when kids become caregivers?

hotspot

comprehensive

focus

Bright Health sells Medicare Advantage business to Molina

How I helped Pfizer think through the ethics of Viagra

Moonlake's readout produced a cash windfall. Risks remain

The a glaring gap in research on serious mental illness and primary care

Apple is now the first public company to be valued at $3 trillion

Medicare slashes safety net hospital payments by nearly $1 billion

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chris Christie meets with Zelenskyy during Ukraine trip

In age of alternative facts, a scholarly course on calling out crap

2 officers injured in shooting in Orlando, police say

hotspot

Pharma showers House GOP doctor with campaign cash

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Late stage cancers on the rise after pandemic delayed screenings

Insmed lung disease drug hits target in key Phase 3 trial

Chris Christie meets with Zelenskyy during Ukraine trip

How to ethically and practically extend health care to all

hotspot

entertainment

explore

hotspot